Geode Capital Management
IMMX icon

Geode Capital Management’s Immix Biopharma IMMX Stock Holding History

Geode Capital Management’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
1,201,097
+737,713
+159% +$6.84M ﹤0.01% 2427
2026
Q1 		$4.22M Buy
463,384
+217,328
+88% +$1.6M ﹤0.01% 2824
2025
Q4 		$1.29M Buy
246,056
+58,580
+31% +$241K ﹤0.01% 3302
2025
Q3 		$392K Buy
187,476
+26,361
+16% +$63.3K ﹤0.01% 3709
2025
Q2 		$334K Buy
161,115
+373
+0.2% +$751 ﹤0.01% 3690
2025
Q1 		$270K Buy
160,742
+10,660
+7% +$20.1K ﹤0.01% 3750
2024
Q4 		$330K Hold
150,082
– – ﹤0.01% 3734
2024
Q3 		$224K Buy
150,082
+7,954
+6% +$16K ﹤0.01% 3867
2024
Q2 		$281K Buy
142,128
+17,358
+14% +$39.9K ﹤0.01% 3788
2024
Q1 		$383K Buy
124,770
+41,343
+50% +$160K ﹤0.01% 3702
2023
Q4 		$577K Buy
83,427
+10,405
+14% +$47.1K ﹤0.01% 3555
2023
Q3 		$250K Buy
73,022
+12,696
+21% +$29.8K ﹤0.01% 3890
2023
Q2 		$162K Sell
60,326
-19,396
-24% -$40.6K ﹤0.01% 4131
2023
Q1 		$145K Buy
79,722
+3,185
+4% +$7.04K ﹤0.01% 4189
2022
Q4 		$175K Sell
76,537
-232
-0.3% -$309 ﹤0.01% 4167
2022
Q3 		$104K Buy
76,769
+3,436
+5% +$7.51K ﹤0.01% 4556
2022
Q2 		$190K Buy
+73,333
New +$143K ﹤0.01% 4298

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management's IMMX Position: Q2 2026 in Review

Geode Capital Management increased its Immix Biopharma (IMMX) stake by 159% in Q2 2026, buying an estimated $6.84M and bringing the position to 1,201,097 shares worth $12.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2427.

Geode Capital Management first reported a position in IMMX in Q2 2022 and has held it in 17 quarters since. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Geode Capital Management held 1,201,097 shares of Immix Biopharma worth $12.4M as of Q2 2026.
  • Geode Capital Management bought 737,713 Immix Biopharma shares in Q2 2026, an estimated $6.84M.
  • Immix Biopharma made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2427 holding.
  • Geode Capital Management first reported a position in Immix Biopharma in Q2 2022 and has held it in 17 quarters since.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.